The GenieFluor Violet 450 Anti-Human CD196 (CCR6) Antibody (G034E3) available at AssayGenie is a cutting-edge tool for researchers studying the CCR6 receptor in human samples. This antibody is a crucial resource for investigations into immune cell migration, specifically targeting CCR6-expressing cells in various research applications. With its high specificity and sensitivity, this antibody enables precise detection and analysis of CCR6, opening new avenues for exploration in immunology and related fields.CCR6, a chemokine receptor expressed on specific immune cells, plays a pivotal role in directing cellular trafficking and mediating immune responses.
Understanding the functions and regulation of CCR6 is essential for unraveling mechanisms underlying various immune-related conditions, including inflammation, autoimmunity, and infectious diseases. Researchers can utilize this antibody to uncover the involvement of CCR6 in these processes, aiding in the development of targeted therapies and treatment strategies.By utilizing the GenieFluor Violet 450 Anti-Human CD196 (CCR6) Antibody (G034E3), scientists can delve deeper into the intricate workings of immune cell interactions and responses, paving the way for innovative discoveries and advancements in immunological research.
Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.
Spectrum:
Swissprot:
P51684
Gene ID:
1235
Storage Buffer:
Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant.
Stability & Storage:
Keep as concentrated solution. Store at 2~8°C and protected from prolonged exposure to light. Do not freeze. Centrifuge before opening to ensure complete recovery of vial contents. This product is guaranteed up to one year from purchase.
Background:
CCR6, also known as CD196/CCR6, is a chemokine receptor that is expressed on immature dendritic cells, B lymphocytes, and memory T cells. CCR6 binds CCL20, although members of the β defensin family also bind CCR6 with a lower affinity. CCR6 positive cells, and its ligand CCL20, have been detected in numerous organs, especially the secondary lymphoid organ. CCL20 is selectively made by the follicle-associated epithelium (FAE) overlying Peyers Patches (PPs) and isolated lymphoid follicles (ILFs). CCL20 contributes to the recruitment of CCR6-expressing B cells to these structures. In humans, CCR6 can function to mediate arrest of T cells on dermal endothelial cells and is highly expressed on T cells resident in both normal and psoriatic skin. CCR6 and/or CCL20 have been implicated in the pathogenesis of rheumatoid arthritis and inflammatory bowel disease. Human T cells that are able to produce IL-17 express CCR6. It suggests that CCL20 and CCR6 have a role in inflammatory diseases by recruiting Th17 cells to target tissues.